Clinical-stage company developing gene therapies for severe genetic and rare diseases.
H.R. 1, The Tax Cut and Jobs Act, as it relates to the orphan drug tax credit. Issues related to novel therapies for rare pediatric populations; issues related to drug pricing; monitored issues related to Right to Try including H.R. 2368 and H.R. 878 and S. 204, Trickett Wendler, Frank Mongiello, Jordan McLinn & Matthew Bellina Right to Try Act of 2017; monitored issues related to gene editing and gene therapy; monitored issues concerning value based contracting. Issues related to Medicaid and CHIP as it relates to rare pediatric diseases. H.R.1370, An Act to amend the Homeland Security Act of 2002, as it relates to further additional appropriations for 2018 and CHIP and PAYGO.
TAX - Taxation/Internal Revenue Code HCR - Health Issues MMM - Medicare/Medicaid BUD - Budget/Appropriations
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
THE NICKLES GROUP, LLC
601 13th St. NW, Suite 250 N, Washington, DC, 20005, US
STACEY HUGHES RACHEL JONES HENSLER (U.S. Senate Budget Committee, Tax Policy Dir.; Office of U.S. Senator Fred Thompson, Legislative Assistant; Office of U.S. Senator Dave Durenberger, Legislative Assistant; Office of U.S. Senator Dave Durenberger, Legislative Correspondent) STACEY HUGHES EMILY PORTER KATHERINE RAAB EMILY PORTER STACEY HUGHES KATHERINE RAAB STACEY HUGHES
U.S. Senate Budget Committee, Tax Policy Dir.; Office of U.S. Senator Fred Thompson, Legislative Assistant; Office of U.S. Senator Dave Durenberger, Legislative Assistant; Office of U.S. Senator Dave Durenberger, Legislative Correspondent